Blida 1 University
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Efficacy of Neoadjuvant Subcutaneous Trastuzumab-Pertuzumab in Algerian Women With Locally Advanced HER2 Positive Breast Cancer (NCT07166185) | Blida 1 University | 2025-03-01 |
Track Blida 1 University automatically
Every clearance here is in the API, with alerts when new ones post.